How to buy Integrated Research shares | A$3.82

Integrated Research Limited is a software—application business based in Australia. Integrated Research shares (IRI) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Its last market close was $3.82 – a decrease of 0.26% over the previous week. Integrated Research has a trailing 12-month revenue of around $110.9 million.

How to buy shares in Integrated Research

1. Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
3. Search for Integrated Research . Find the share by name or ticker symbol: IRI. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Integrated Research reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At today's price of $3.82, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
6. Check in on your investment. Congratulations, you own a part of Integrated Research . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

🧪How we chose these brokers

For our Top Picks, we compared our Finder partners using a proprietary algorithm in August 2020. Keep in mind that our top picks may not always be the best for you, and you're encouraged to compare for yourself to find one that works for you. Read our full methodology here to find out more.

How has coronavirus impacted Integrated Research 's share price?

Since the stock market crash in March caused by coronavirus, Integrated Research 's share price has had significant positive movement.

Its last market close was $3.82, which is 19.90% up on its pre-crash value of $3.06 and 74.43% up on the lowest point reached during the March crash when the shares fell as low as $2.19.

If you had bought $1,000 worth of Integrated Research shares at the start of February 2020, those shares would have been worth $817.86 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,312.70.

Integrated Research share price

Use our graph to track the performance of IRI stocks over time.

Integrated Research shares at a glance

• Key figures

Information last updated 2020-10-20.

Latest market close	AUDA$3.82
52-week range	AUDA$2.19 - AUDA$4.92
50-day moving average	AUDA$3.6839
200-day moving average	AUDA$3.6539
Target price	AUDA$2.6
PE ratio	27.4749
Dividend yield	AUDA$0.07 (1.97%)
Earnings per share (TTM)	AUDA$0.139

Share Trading Account Offer

IG Share Trading Offer

AUD 8

Standard brokerage - Australian shares

Share Trading Account Offer

Competitive broker fees on Australian and international shares

• Brokerage - AU shares: From AUD 5 or 0.05%
• Brokerage - US shares: USD 0
• Sign-up process: Instant
• Support - After hours: Yes

Go to site

More info

Important: Share trading carries risk of capital loss.

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.

Is it a good time to buy Integrated Research stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Integrated Research Limited by TradingView

Integrated Research price performance over time

Historical closes compared with the close of A$3.82 on 2020-10-22

1 week (2020-10-15)	1.87%
1 month (2020-09-25)	6.11%
3 months (2020-07-24)	-1.80%
6 months (2020-04-24)	31.72%

1 year (2019-10-24)	35.46%
2 years (2018-10-24)	66.81%
3 years (2017-10-24)	0.79%
5 years (2015-10-23)	59.17%

Is Integrated Research under- or over-valued?

Valuing Integrated Research stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Integrated Research 's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Integrated Research 's P/E ratio

Integrated Research 's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 27x. In other words, Integrated Research shares trade at around 27x recent earnings.

That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Integrated Research 's EBITDA

Integrated Research 's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $33.9 million.

The EBITDA is a measure of a Integrated Research 's overall financial performance and is widely used to measure a its profitability.

Integrated Research financials

Revenue TTM	$110.9 million
Operating margin TTM	29.51%
Gross profit TTM	$110.9 million
Return on assets TTM	16.15%
Return on equity TTM	31.58%
Profit margin	21.69%
Book value	0.48
Market capitalisation	$654.3 million

TTM: trailing 12 months

Integrated Research share dividends

Dividend payout ratio: 51.79% of net profits

Recently Integrated Research has paid out, on average, around 51.79% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.97% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Integrated Research shareholders could enjoy a 1.97% return on their shares, in the form of dividend payments. In Integrated Research 's case, that would currently equate to about A$0.07 per share.

Integrated Research 's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.

The latest dividend was paid out to all shareholders who bought their shares by 1 September 2020 (the "ex-dividend date").

Integrated Research share price volatility

Over the last 12 months, Integrated Research 's shares have ranged in value from as little as $2.19 up to $4.92. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Integrated Research 's is 0.8454. This would suggest that Integrated Research 's shares are less volatile than average (for this exchange).

Integrated Research overview

Integrated Research Limited designs, develops, implements, and sells systems and applications management computer software for business-critical computing, unified communication networks, and payment networks in the Americas, Europe, and the Asia Pacific. The company offers Prognosis, an integrated suite of monitoring and management software designed to give an organization's management and technical personnel operational insight into the HP NonStop platform, distributed system servers, unified communications, payment environments, and the business applications that run on these platforms. It also provides testing, maintenance, and software as a service solutions, as well as professional services. The company serves stock exchanges, banks, credit card companies, telecommunications carriers, service providers, and manufacturing companies through sales offices, as well as through a distribution network. Integrated Research Limited was founded in 1988 and is based in North Sydney, Australia.

Frequently asked questions

• What percentage of Integrated Research is owned by insiders or institutions?

  Currently 43.354% of Integrated Research shares are held by insiders and 3.225% by institutions.

• When does the fiscal year end for Integrated Research ?

  Integrated Research 's fiscal year ends in June.

• Where is Integrated Research based?

  Integrated Research 's address is: 100 Pacific Highway, North Sydney, NSW, Australia, 2060

• What is Integrated Research 's ISIN number?

  Integrated Research 's international securities identification number is: AU000000IRI3